FIELD: medicine; pharmacology.
SUBSTANCE: invention concerns a pharmaceutical composition for treatment of the arthritises, containing in the structure as the first active ingredient antagonist of P2X7-receptor, and as the second active ingredient celecocsib, either rofecocsib, or valdecocsib. The invention also concerns the method of obtaining of the specified composition, its application for treatment of arthritises, to the method of treatment of arthritises, a pharmaceutical product and a set for treatment of arthritises.
EFFECT: increased efficiency at treatment of arthritises.
13 cl, 6 ex, 3 tbl
| Title |
Year |
Author |
Number |
| PHARMACEUTICAL COMPOSITION, CONTAINING ANTAGONIST P2X OF RECEPTOR AND FACTOR OF TUMOUR NECROSIS α |
2004 |
|
RU2350354C2 |
| DERIVATIVES OF ADAMANTANE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION |
1998 |
- Behkster Ehndrju
- Makinalli Tomas
- Mortimor Majkl
- Klehdingboehl' Dehvid
|
RU2214997C2 |
| DERIVATIVES OF ADAMANTANE, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR ITS PREPARING, METHODS FOR TREATMENT OF RHEUMATIC ARTHRITIS AND LUNG CHRONIC OBSTRUCTIVE DISEASE |
2000 |
- Al'Kara Lilian
- Kehffri Moja
- Ferber Mark
- Luker Timoti
- Mortimor Majkl
- Pimm Osten
- Torn Fillip
- Villis Pol
|
RU2272025C2 |
| DERIVATIVES OF ADAMANTANE, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR TREATMENT |
2000 |
- Al'Kara Lilian
- Ferber Mark
- Mortimor Majkl
|
RU2254333C2 |
| DERIVATIVES OF ADAMANTANE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF ITS PREPARING AND METHOD OF EFFECT ON IMMUNE SUPPRESSION |
1998 |
- Behkster Ehndrju
- Braf Stefen
- Makinalli Tomas
- Mortimor Majkl
- Klehdingboehl' Dehvid
|
RU2197477C2 |
| APPLICATION OF CRTH2 ANTAGONISTS IN THERAPY |
2004 |
- Midlemis Devid
- Ehshton Mark Richard
- Bojd Ehdvard Ehndrju
- Brukfild Frederik Artur
- Petifer Ehrik Roj
- Vittaker Mark
- Palmer Kristofer
- Khanter Mik
|
RU2412934C2 |
| 8-CARBAMOYL-2-(2,3-DI-SUBSTITUTED PYRID-6-YL)-1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES AS APOPTOSIS-INDUCING AGENTS FOR CANCER TREATMENT |
2012 |
- Vang Li
- Douerti Dzhordzh
- Van Silu
- Tao Chzhi-Fu
- Branko Milan
- Kanzer Aaron R.
- Uendt Majkl D.
- Sun Syaokhun
- Frej Robin
- Khansen Todd M.
- Sallivan Dzherard M.
- Dzhadd Endryu
- Sauers Endryu
|
RU2625315C2 |
| QUINAZOLINE DERIVATIVES EFFECTIVE AS VANILOID ANTAGONISTS |
2005 |
- Ritchi Timoti Dzhon
- Kalsho Ehndr'Ju Dzhejms
- Brejn Kristofer Tomas
- Dzjadulevich Ehduard Karol
- Khart Terens
|
RU2396261C2 |
| COMBINED PRODUCTS CONTAINING TYROSINE KINASE INHIBITORS AND THEIR USE |
2013 |
- Tidt Ralf
- Shatene-Rivode Kristian
- Ito Moriko
- Pen Bin
- Gun In
- Akimov Mikhail
|
RU2660354C2 |
| SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR MODULATORS AND USING THEM FOR TREATING MUSCULAR TISSUE INFLAMMATION |
2009 |
- Sajid Sokhajl Akhmed
- Marko Londej
- Timoti Rajt
- Peter Gergeli
|
RU2521286C2 |
